ArticleJournal of hematology & oncology2021

Intracellular delivery of anti-BCR/ABL antibody by PLGA nanoparticles suppresses the oncogenesis of chronic myeloid leukemia cells.

Guoyun Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.